At A Glance
1
The Company as of 2021 is now in process of seeking a merger or acquisition candidate and working to bring the Company current.
2
No significant events in the past 90 days.
—
Market Cap
—
Revenue
—
Net Income
Fundamentals
How The Business Makes Money
The Company as of 2021 is now in process of seeking a merger or acquisition candidate and working to bring the Company current. Effective October 9, 2017 the PSA Agreement with Canteck Pharma, inc. was rescinded do inability to proceed with the license for Mexico that previously had focused on its immunotherapeutic based technology specific to Cancer indication.
Industry Biotechnology
Activity
What Changed Recently
No significant events in the past 90 days.
Company Profile
CIK0001495028
ISINUS0702491079
CUSIP070249107
Phone714-907-1241
Address300 South El Camino Real, San Clemente, CA, 92672, US
SEC EDGAR